Literature DB >> 7317687

Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.

R J Marshall, A W Muir, E Winslow.   

Abstract

1 The antidysrhythmic and haemodynamic effects of the aminosteroid, Org 6001, were studied in the rat anaesthetized with pentobarbitone. Mexiletine was used for comparison. 2 Both Org 6001 (2--10 mg/kg) and mexiletine (1 mg/kg) given intravenously antagonized the development of dysrhythmias evoked by acute coronary artery ligation in rats. 3 In antidysrhythmic doses, Org 6001 and mexiletine exerted only moderate and transient hypotension and depression of cardiac contractility (assessed from LV dP/dtmax). Org 6001 did, however, induce a more sustained bradycardia. 4 Effective oral doses of Org 6001 (20--100 mg/kg) were similar to those of mexiletine, disopyramide and propafenone. 5 Oral Org 6001 (100 mg/kg) was effective for 18 h whereas mexiletine (100 mg/kg) failed to protect against evoked dysrhythmias 3 h after dosing. 6 Org 6001 and mexiletine differed in their actions on ventricular fibrillation threshold (VFT). Org 6001 (100 mg/kg orally 12 h before ligation) prevented the decrease in VFT produced by coronary ligation whereas mexiletine (100 mg/kg orally) had no effect. When administered intravenously, mexiletine (but not ORg 6001) increased VFT in normal ventricular muscle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317687      PMCID: PMC2071715          DOI: 10.1111/j.1476-5381.1981.tb09982.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.

Authors:  L A Salako; V Williams; J H Wittig
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

2.  ORG 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride), a steroidal anti-arrhythmic agent.

Authors:  B B Vargaftig; M F Sugrue; W R Buckett; H van Riezen
Journal:  J Pharm Pharmacol       Date:  1975-09       Impact factor: 3.765

Review 3.  New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.

Authors:  D P Zipes; P J Troup
Journal:  Am J Cardiol       Date:  1978-05-22       Impact factor: 2.778

4.  The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats.

Authors:  K A Kane; I Leprán; F M McDonald; J R Parratt; L Szekeres
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

Review 5.  Comparative mechanisms of action of antiarrhythmic drugs.

Authors:  B N Singh; O Hauswirth
Journal:  Am Heart J       Date:  1974-03       Impact factor: 4.749

6.  Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.

Authors:  W J Remme; P D Verdouw; F Hagemeyer
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

7.  Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.

Authors:  M Arita; M Goto; Y Nagamoto; T Saikawa
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.

Authors:  I Yamaguchi; B N Singh; W J Mandel
Journal:  Cardiovasc Res       Date:  1979-05       Impact factor: 10.787

9.  Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors:  C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharmacol Methods       Date:  1980-06

10.  The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.

Authors:  J D Allen; J M Ekue; R G Shanks; S A Zaidi
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

View more
  4 in total

1.  Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.

Authors:  R J Marshall; A W Muir; E Winslow
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

2.  Synergistic interaction between histamine and ouabain on ventricular fibrillation threshold.

Authors:  J P Trzeciakowski
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

3.  Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.

Authors:  Y Hashimoto; R Hori; K Okumura; M Yasuhara
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

4.  Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.

Authors:  S Komori; S Sano; B H Li; K Matsumura; A Naitoh; S Mochizuki; T Ishihara; A Watanabe; K Umetani; H Ijiri
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.